Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 12, 2008, Pages 1783-1786

  Kocabora, M Selim ^a,b   Durmaz, Sahan ^a   Kandemir, Nilay ^a  

^a VAKIF GUREBA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Anticardiolipin antibodies; Central serous chorioretinopathy; Intravitreal triamcinolone acetonide; Retinal vein occlusion

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRIAMCINOLONE;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; BIOMICROSCOPY; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; METAMORPHOSIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULA CYSTOID EDEMA; RETINA PIGMENT DEGENERATION; THROMBOSIS; VASCULAR THROMBOSIS; VISUAL ACUITY; VISUAL FIELD DEFECT;

CHOROID DISEASES; DISEASE PROGRESSION; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RECURRENCE; RETINAL DETACHMENT; RETINAL DISEASES; RETINAL VEIN OCCLUSION; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISION DISORDERS; VISUAL ACUITY; VITREOUS BODY;

EID: 56049083003     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0932-2     Document Type: Article

References (10)

1. Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431-448 doi: 10.1016/S0039-6257(02)00338-7
2. Costen MT, Olson JA (2000) Central serous chorioretinopathy may be a manifestation of the primary antiphospholipid syndrome. Br J Ophthalmol 84:667 doi: 10.1136/bjo.84.6.667
3. Imasawa M, Ohshiro T, Gotoh T, Imai M, Iijima H (2005) Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema. Acta Ophthalmol Scand 83:132-133 doi: 10.1111/j.1600-0420.2005.00379.x
4. Jonas JB (2005) Intravitreal triamcinolone acetonide for treatment of intraocular edematous and neovascular diseases. Acta Ophthalmol Scand 83:645-663 doi: 10.1111/j.1600-0420.2005.00592.x
5. Jonas JB, Kamppeter BA (2005) Intravitreal triamcinolone acetonide and central serous chorioretinopathy. Br J Ophthalmol 89:386-387 doi: 10.1136/bjo.2004.054247
6. Karacorlu M, Ozdemir H, Karacorlu SA (2005) Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion. Retina 25:856-860 doi: 10.1097/00006982-200510000-00007
7. Karadimas P, Bouzas EA (2004) Glucocorticoid use represents a risk factor for central serous chorioretinopathy: A prospective, case-control study. Graefes Arch Clin Exp Ophthalmol 242:800-802 doi: 10.1007/ s00417-004-0885-z
8. Leo-Kottler B, Klein R, Berg PA, Zrenner E (1998) Ocular symptoms in association with antiphospholipid antibodies. Graefes Arch Clin Exp Ophthalmol 236:658-668 doi: 10.1007/s004170050138
9. Yamaguchi Y, Otani T, Kishi S (2006) Serous macular detachment in branch retinal vein occlusion. Retina 26:1029-1033 doi: 10.1097/ 01.iae.0000254893.94013.16
10. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol (Copenh) 86:126-145 doi: 10.1111/j.1600-0420.2007.00889.x